Aktienanalyse zu InnovAge Holding Corp (INNV)INNVInnovAge Holding Corp

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

InnovAge Holding Corp is currently trading at $8.85, which is below the analyst price target of $14, indicating potential upside. However, the stock has a low RSI of 28.335, suggesting it may be oversold, but recent insider selling has increased by 105.94%, which raises concerns about market confidence. The forward P/E ratio is 13.66, which is reasonable, but the recent secondary offering at $9.25 may dilute existing shares and negatively impact the stock price in the short term.